Global Pimozide Market Survey and Trend Research 2018

September 2018 | 75 pages | ID: GD4B7BBB6A9EN
99Strategy

Abstracts

Summary

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Domina Pharmaceuticals, Domina Pharmaceuticals, Aa Pharma etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Pimozide Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 PIMOZIDE MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Teva (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Par Pharmaceutical (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Eumedica (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Domina Pharmaceuticals (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Domina Pharmaceuticals (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Aa Pharma (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Pimozide Market 2012-2017, by Type, in USD Million
Table Global Pimozide Market Forecast 2018-2023, by Type, in USD Million
Table Teva Overview List
Table Pimozide Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
Table Par Pharmaceutical Overview List
Table Pimozide Business Operation of Par Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Pimozide Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Eumedica Overview List
Table Pimozide Business Operation of Eumedica (Sales Revenue, Cost, Gross Margin)
Table Domina Pharmaceuticals Overview List
Table Pimozide Business Operation of Domina Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Domina Pharmaceuticals Overview List
Table Pimozide Business Operation of Domina Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Aa Pharma Overview List
Table Pimozide Business Operation of Aa Pharma (Sales Revenue, Cost, Gross Margin)
Table Global Pimozide Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Pimozide Sales Revenue Share, by Companies, in USD Million
Table Pimozide Demand 2012-2017, by Application, in USD Million
Table Pimozide Demand Forecast 2018-2023, by Application, in USD Million
Table Global Pimozide Market 2012-2017, by Region, in USD Million
Table Pimozide Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Pimozide Industry Chain Structure
Figure Global Pimozide Market Growth 2012-2017, by Type, in USD Million
Figure Global Pimozide Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region